Table 1. Demographic characteristics and prevalence of psychotropic use in different university hospital districts in 2005 and 2011.
Data are given as n (%) unless otherwise indicated.
| 2005 | 2011 | P for temporal change | |||
|---|---|---|---|---|---|
| N (n eligible*) | N (n eligible*) | ||||
| Age, mean (SD) | |||||
| Helsinki | 2,126 (2,104) | 79.5 (6.9) | 6,868 (6,614) | 80.4 (7.6) | <0.001 |
| Kuopio | 1,673 (1,654) | 79.3 (6.8) | 4,790 (4,612) | 80.3 (6.9) | <0.001 |
| Oulu | 1,350 (1,342) | 78.9 (6.5) | 3,117 (3,054) | 80.3 (7.1) | <0.001 |
| Tampere | 1,961 (1,942) | 79.4 (6.7) | 5,013 (4,820) | 80.6 (7.1) | <0.001 |
| Turku | 1,410 (1,397) | 79.9 (6.5) | 3,249 (3,159) | 81.1 (7.1) | <0.001 |
| P for regional difference | 0.002 | <0.001 | |||
| Sex, women | |||||
| Helsinki | 2,126 (2,104) | 1,398 (66.4) | 6,868 (6,614) | 4,314 (65.2) | 0.31 |
| Kuopio | 1,673 (1,654) | 1,055 (63.8) | 4,790 (4,612) | 2,947 (63.9) | 0.93 |
| Oulu | 1,350 (1,342) | 839 (62.5) | 3,117 (3,054) | 1,924 (63.0) | 0.76 |
| Tampere | 1,961 (1,942) | 1,269 (65.4) | 5,013 (4,820) | 3,065 (63.6) | 0.17 |
| Turku | 1,410 (1,397) | 933 (66.8) | 3,249 (3,159) | 2,066 (65.4) | 0.36 |
| P for regional difference | 0.07 | 0.10 | |||
| Antidementia medication use | |||||
| Helsinki | 2,126 (2,104) | 1,205 (57.3) | 6,868 (6,614) | 4,867 (74.6) | <0.001 |
| Kuopio | 1,673 (1,654) | 1, 055 (63.8) | 4,790 (4,612) | 3,596 (78.0) | <0.001 |
| Oulu | 1,350 (1,342) | 853 (63.6) | 3,117 (3,054) | 2,348 (76.9) | <0.001 |
| Tampere | 1,961 (1,942) | 1,260 (64.9) | 5,013 (4,820) | 3,690 (76.6) | <0.001 |
| Turku | 1,410 (1,397) | 780 (55.8) | 3,249 (3,159) | 2,317 (73.4) | <0.001 |
| P for regional difference | <0.001 | <0.001 | |||
| Any psychotropic, prevalent use | |||||
| Helsinki | 2,126 (2,104) | 1,067 (50.7) | 6,868 (6,614) | 3,064 (46.3) | <0.001 |
| Kuopio | 1,673 (1,654) | 767 (46.4) | 4,790 (4,612) | 2,076 (45.0) | 0.34 |
| Oulu | 1,350 (1,342) | 600 (44.7) | 3,117 (3,054) | 1,377 (45.1) | 0.82 |
| Tampere | 1,961 (1,942) | 952 (49.0) | 5,013 (4,820) | 2,292 (47.6) | 0.27 |
| Turku | 1,410 (1,397) | 690 (49.4) | 3,249 (3,159) | 1,512 (47.9) | 0.34 |
| P for regional difference | 0.004 | 0.027 | |||
| Antipsychotics, prevalent use | |||||
| Helsinki | 2,126 (2,104) | 341 (16.2) | 6,868 (6,614) | 1,043 (15.8) | 0.63 |
| Kuopio | 1,673 (1,654) | 303 (18.3) | 4,790 (4,612) | 789 (17.1) | 0.27 |
| Oulu | 1,350 (1,342) | 173 (12.9) | 3,117 (3,054) | 490 (16.0) | 0.007 |
| Tampere | 1,961 (1,942) | 301 (15.5) | 5,013 (4,820) | 820 (17.0) | 0.13 |
| Turku | 1,410 (1,397) | 224 (16.0) | 3,249 (3,159) | 554 (17.5) | 0.21 |
| P for regional difference | 0.002 | 0.12 | |||
| Antidepressants, prevalent use | |||||
| Helsinki | 2,126 (2,104) | 595 (28.3) | 6,868 (6,614) | 1,775 (26.8) | 0.20 |
| Kuopio | 1,673 (1,654) | 368 (22.3) | 4,790 (4,612) | 1,031 (22.4) | 0.93 |
| Oulu | 1,350 (1,342) | 316 (23.6) | 3,117 (3,054) | 693 (22.7) | 0.54 |
| Tampere | 1,961 (1,942) | 491 (25.3) | 5,013 (4,820) | 1,192 (24.7) | 0.63 |
| Turku | 1,410 (1,397) | 368 (26.3) | 3,249 (3,159) | 768 (24.3) | 0.14 |
| P for regional difference | <0.001 | <0.001 | |||
| BZDR, prevalent use | |||||
| Helsinki | 2,126 (2,104) | 596 (28.3) | 6,868 (6,614) | 1,535 (23.2) | <0.001 |
| Kuopio | 1,673 (1,654) | 433 (26.2) | 4,790 (4,612) | 1,038 (22.5) | 0.003 |
| Oulu | 1,350 (1,342) | 376 (28.0) | 3,117 (3,054) | 731 (23.9) | 0.004 |
| Tampere | 1,961 (1,942) | 604 (31.1) | 5,013 (4,820) | 1,202 (24.9) | <0.001 |
| Turku | 1,410 (1,397) | 399 (28.6) | 3,249 (3,159) | 770 (24.4) | 0.003 |
| P for regional difference | 0.027 | 0.050 | |||
*AD diagnosis not more than one year ago and not hospitalised/institutionalised for the entire assessment period